The rapid rise of weight loss drugs Wegovy and Mounjaro is generating a host of new product lines as companies hope to land on the right side of the health care disruptor.
LONDON — The rapid rise of weight loss drugs like Wegovy and Mounjaro is generating a host of new product lines as companies hope to land on the right side of the health care disruptor.Industries spanning food and beverage to retail and fitness have come under the spotlight amid surging demand for Novo Nordisk and Eli Lilly's so-called miracle drugs over concerns that they could dramatically shift consumer habits.
Whether weight loss meds will leave consumers more or less likely to reach for healthy products is not yet certain, however, according to Barclays analysts. Such shifts could have similar implications for restaurants, food retailers and delivery companies that"proactively pivot" to embrace the drugs, the bank's analysts added. It cited fast food companies including KFC's Yum Brands and Shake Shack as potential beneficiaries if consumers view the drugs as"offsetting" such indulgences.
Asked whether rising demand for nutritional products was being reflected in his company's share price, de Vreeze acknowledged it was"too early" to say.